Back to search
FDAFDA · Food and drugs·Recall number D-0079-2027

Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014, India; Distributed by: Strides Pharma Inc. Bridgewater, NJ 08807, NDC 64380-883-04

Published October 28, 2026 · Recall initiated: October 7, 2026

Summary

FDA records drug Class II recall D-0079-2027, published October 28, 2026 and initiated October 7, 2026. Recalling firm: STRIDES PHARMA INC; Status: Ongoing; Reported quantity: 49,488 30-count bottles; Lot: Lot # 7717825A, Expiry: 11/30/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if CINACALCET has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CINACALCET
Manufacturer
STRIDES PHARMA INC
Distributor
US Nationwide
UPC
0364380885047
Lot
Lot # 7717825A, Expiry: 11/30/2028.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014, India; Distributed by: Strides Pharma Inc. Bridgewater, NJ 08807, NDC 64380-883-04 recalled?

Yes. FDA published recall D-0079-2027 on October 28, 2026. Reported hazard: Failed dissolution specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CINACALCET. UPC: 0364380885047.